Exabis Library
Welcome to the e-CCO Library!
P470: Comparative effectiveness analysis of flares, hospitalisations, and corticosteroid use among biologic naïve patients with inflammatory bowel disease within 12 months of initiation of vedolizumab or infliximab
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
P470: DUBLIN (Degree of Ulcerative colitis Burden of Luminal INflammation) score, a simple method to quantify inflammatory burden in ulcerative colitis
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
P470: Early change in faecal calprotectin during anti-TNFα initiation is strongly predictive of outcome in Crohn’s disease
2016
ECCO '16 Amsterdam
Friday, 22 February 2019, 9:49 AM
P470: Evolution of asymptomatic unresected lesions in patients operated for multifocal Crohn's disease.
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 11:05 AM
P470: Improving IBD-related pregnancy knowledge with a specialised preconception and pregnancy in IBD clinic
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
P470: Real-world characteristics and complications of patients with Ulcerative Colitis receiving conventional therapy in the public healthcare system in Brazil
2022
ECCO'22
Friday, 11 February 2022, 3:52 PM
P470: Ustekinumab Trough Levels are not Associated with Clinical Response in Inflammatory Bowel Disease Patients
2021
ECCO'21 Virtual
Wednesday, 2 June 2021, 4:12 PM
P471 What is the appropriate cut-off value of CRP to predict endoscopic remission in ulcerative colitis patients with clinical remission?
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
P471: A Transcriptome-dependent Prognostic Model of Response in Patients with Ulcerative Colitis
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 11:05 AM
P471: Association of vedolizumab levels with clinical and biochemical markers of inflammation during maintenance therapy in inflammatory bowel disease
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
P471: Clinical characteristics and complications in hospitalised elderly patients with ulcerative colitis in a real-world specialised hospital
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
P471: Efficacy and safety of switching from reference infliximab to biosimilar infliximab in patients with inflammatory bowel disease: first French experience
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
P471: Predictors of bowel damage in long term progression of Crohn’s disease
2021
ECCO'21 Virtual
Wednesday, 2 June 2021, 4:12 PM
P471: Real-world experience of using Tofacitinib in Ulcerative Colitis in biologic naïve and biologic exposed patients
2022
ECCO'22
Friday, 11 February 2022, 3:52 PM
P471: Safety analysis of multimatrix mesalazine amongst patients with ulcerative colitis or recurrent diverticulitis ≥ 55 years of age
2016
ECCO '16 Amsterdam
Friday, 22 February 2019, 9:49 AM
P472 Optimising the development of apps for the management of inflammatory bowel disease and participation in clinical trials
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
P472: Changes in colectomy for Ulcerative Colitis during the last two decades: an in-depth retrospective analysis
2022
ECCO'22
Friday, 11 February 2022, 3:52 PM
P472: Cyclosporine versus infliximab in patients with Acute Severe Ulcerative Colitis: A single-centre retrospective study
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 11:05 AM
P472: Efficacy of intravenous ustekinumab re-induction in patients with Crohn’s disease with a loss of response
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
P472: Faecal calprotectin as a biomarker of early mucosal healing in patients with ulcerative colitis naïve to adalimumab treatment
2016
ECCO '16 Amsterdam
Friday, 22 February 2019, 9:49 AM